Clinical Trials Directory

Trials / Completed

CompletedNCT00661895

Black Education and Treatment of Hypertension (BEAT HTN)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Creighton University · Academic / Other
Sex
All
Age
25 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Clinical trials have yet to test the adequacy of HTN control in African Americans (AA) when both control and intervention groups are given free antihypertensive medications and are involved in usual versus intensive intervention strategies. Because of this, it has not yet been determined whether the method of prescribing antihypertensive medications according to JNC 7 guidelines is more, less, or equally as effective as prescribing antihypertensive medications and providing intensive behavioral and clinical interventions. Knowledge in this area of HTN treatment should better able medical and health practitioners to help their AA subjects control HTN. The BEAT Hypertension Clinic will evaluate this method of HTN control by proposing a program that will evaluate the difference in HTN control among subjects receiving usual care and free medications and subjects also receiving free medications, but additionally being treated in a clinic that operates in a more intensive manner in relationship to patient behavior modification, patient-clinician interactions, and physical and social environments. At the conclusion of the study, the BEAT Hypertension Clinic investigators will report findings and help to answer the question of whether medication alone or medication combined with intensive behavioral and clinical treatment is more effective in HTN control in the AA population.

Conditions

Interventions

TypeNameDescription
DRUGHydrochlorothiazideHydrochlorothiazide 25 mg tablets
DRUGLisinoprilLisinopril 5mg Tablet, 10 mg tablet, 20 mg tablet
DRUGLisinopril and HydrochlorothiazideL 10 mg and H 12.5 mg tablets, L 20 mg and H 12.5 mg tablets, L 20 mg and H 25 mg tablets
DRUGNifedipine XL30 mg extended release tablets, 60 mg extended release tablets
DRUGMetoprolol tartrate50 mg tablets \& 100 mg tablets
DRUGAtenolol50 mg tablet
DRUGValsartan80 mg tablets \& 160 mg tablet
DRUGDoxazosin4 mg tablets
DRUGClonidine0.2 mg tablets
DRUGHydralazine50 mg tablets
DRUGMetoprolol succinate50 mg tablet \& 100 mg tablet
DRUGAmlodipine5 mg tablets \& 10 mg tablets

Timeline

Start date
2005-08-01
Primary completion
2009-08-01
Completion
2009-11-01
First posted
2008-04-21
Last updated
2012-12-04
Results posted
2012-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00661895. Inclusion in this directory is not an endorsement.